Deep Track Capital, LP Heron Therapeutics, Inc. Transaction History

Deep Track Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.11 - $2.88 $1.27 Million - $3.31 Million	-1,148,018 Reduced 35.49%	2,086,704 $2.42 Million
Q1 2023 May 15, 2023	SELL	$1.51 - $3.25 $4.93 Million - $10.6 Million	-3,262,254 Reduced 50.21%	3,234,722 $4.88 Million
Q4 2022 Feb 14, 2023	SELL	$2.25 - $4.67 $4.62 Million - $9.58 Million	-2,051,411 Reduced 24.0%	6,496,976 $16.2 Million
Q3 2022 Nov 14, 2022	BUY	$2.66 - $5.37 $22.7 Million - $45.9 Million	8,548,387 New	8,548,387 $36.1 Million

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.